Intellectual Property Law and Copyright Laws

A recent decision of the Court of Appeal of the UPC has held that the UPC must interpret its own substantive and procedural law in line with EU law, but that the UPC cannot request the CJEU...

The High Court has confirmed that in cross-undertakings as to damages, an injured party is not entitled to an account of profits.

In G1/24, the Enlarged Board of Appeal (EBA) codified how claims should be interpreted for assessing patentability: in consultation with the description.

Trends in the food and beverage industry can move quickly, and food science and development is a vibrant field of technology with over £5.8bn of investment in 2024, and around 10,000 new products launched annually.

While Coca-Cola has not officially confirmed any changes to its U.S. recipe, there are indications that a shift from the use of corn syrup to cane sugar may be on the horizon.

The European Commission recently launched a public consultation on the implementation of the AI Act, primarily focused on the classification...

In February 2010 we reported on the new powers of the Information Commissioner’s Office ("ICO") to impose penalties on data controllers who commit serious contraventions of the data protection principles.

The latest review of the UK’s intellectual property laws announced by David Cameron in November 2010 proposes to "make them fit for the internet age".

Welcome to our Spring Technology and IP eBulletin. To coincide with the 10th Anniversary of World Intellectual Property Day today, Monday 26 April 2010, we have put together a number of interesting articles which focus on some of the day to day issues raised by World IP Day.

The concept of self-conducted diagnostic tests, administered by patients in their own home, would likely have been thought completely preposterous 100 years ago – conjuring-up images of an array of test-tubes, flasks and Bunsen burners.

The Court of Justice of the European Union (CJEU) ruled yesterday in an important case (C-125/10, Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt), relating to Supplementary Protection Certificates (SPCs).

On 2 November 2011, the UK Supreme Court (formerly the House of Lords) handed down its decision in Human Genome Sciences Inc (HGS) v Eli Lilly and Company (Lilly), which was primarily concerned with the issue of industrial applicability of claimed biological material.